相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Diverse diseases from a ubiquitous process: The ribosomopathy paradox
Joy Armistead et al.
FEBS LETTERS (2014)
ProteomeXchange provides globally coordinated proteomics data submission and dissemination
Juan A. Vizcaino et al.
NATURE BIOTECHNOLOGY (2014)
p53 Acts as a Safeguard of Translational Control by Regulating Fibrillarin and rRNA Methylation in Cancer
Virginie Marcel et al.
CANCER CELL (2013)
Severity of X-linked Dyskeratosis Congenita (DKCX) Cellular Defects Is not Directly Related to Dyskerin (DKC1) Activity in Ribosomal RNA Biogenesis or mRNA Translation
Naresh R. Thumati et al.
HUMAN MUTATION (2013)
Dyskerin depletion increases VEGF mRNA internal ribosome entry site-mediated translation
Laura Rocchi et al.
NUCLEIC ACIDS RESEARCH (2013)
H/ACA Small RNA Dysfunctions in Disease Reveal Key Roles for Noncoding RNA Modifications in Hematopoietic Stem Cell Differentiation
Cristian Bellodi et al.
CELL REPORTS (2013)
Super-SILAC Allows Classification of Diffuse Large B-cell Lymphoma Subtypes by Their Protein Expression Profiles
Sally J. Deeb et al.
MOLECULAR & CELLULAR PROTEOMICS (2012)
Ribosome defects in disorders of erythropoiesis
Anupama Narla et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2011)
Decreased dyskerin levels as a mechanism of telomere shortening in X-linked dyskeratosis congenita
Erin M. Parry et al.
JOURNAL OF MEDICAL GENETICS (2011)
rRNA Pseudouridylation Defects Affect Ribosomal Ligand Binding and Translational Fidelity from Yeast to Human Cells
Karen Jack et al.
MOLECULAR CELL (2011)
Ribosomopathies: human disorders of ribosome dysfunction
Anupama Narla et al.
BLOOD (2010)
Novel Dyskerin-Mediated Mechanism of p53 Inactivation through Defective mRNA Translation
Lorenzo Montanaro et al.
CANCER RESEARCH (2010)
Loss of Function of the Tumor Suppressor DKC1 Perturbs p27 Translation Control and Contributes to Pituitary Tumorigenesis
Cristian Bellodi et al.
CANCER RESEARCH (2010)
Deregulation of oncogene-induced senescence and p53 translational control in X-linked dyskeratosis congenita
Cristian Bellodi et al.
EMBO JOURNAL (2010)
Quantitative Proteomics Reveals Subset-Specific Viral Recognition in Dendritic Cells
Christian A. Luber et al.
IMMUNITY (2010)
MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification
Juergen Cox et al.
NATURE BIOTECHNOLOGY (2008)
Dyskeratosis congenita: a genetic disorder of many faces
M. Kirwan et al.
CLINICAL GENETICS (2008)
Human ribosomal protein L13a is dispensable for canonical ribosome function but indispensable for efficient rRNA methylation
Sujan Chaudhuri et al.
RNA (2007)
Differentiating between Near- and Non-Cognate Codons in Saccharomyces cerevisiae
Ewan P. Plant et al.
PLOS ONE (2007)
Dyskerin expression influences the level of ribosomal RNA pseudo-uridylation and telomerase RNA component in human breast cancer
L. Montanaro et al.
JOURNAL OF PATHOLOGY (2006)
Impaired control of IRES-mediated translation in X-linked dyskeratosis congenita
A Yoon et al.
SCIENCE (2006)
Rapid and simple comparison of messenger RNA levels using real-time PCR
AA Dussault et al.
BIOLOGICAL PROCEDURES ONLINE (2006)
Effects of osmolarity, ions and compatible osmolytes on cell-free protein synthesis
M Brigotti et al.
BIOCHEMICAL JOURNAL (2003)
Dyskeratosis congenita and cancer in mice deficient in ribosomal RNA modification
D Ruggero et al.
SCIENCE (2003)
Internal ribosome entry sites in eukaryotic mRNA molecules
CUT Hellen et al.
GENES & DEVELOPMENT (2001)
Identification of novel DKC1 mutations in patients with dyskeratosis congenita:: implications for pathophysiology and diagnosis
SW Knight et al.
HUMAN GENETICS (2001)